Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) FCF Margin (2019 - 2025)

Historic FCF Margin for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 12.41%.

  • Legend Biotech's FCF Margin rose 584500.0% to 12.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 30.63% for FY2024, which is 1305300.0% up from last year.
  • Per Legend Biotech's latest filing, its FCF Margin stood at 12.41% for Q3 2025, which was up 584500.0% from 1.5% recorded in Q2 2025.
  • Legend Biotech's FCF Margin's 5-year high stood at 23.15% during Q1 2024, with a 5-year trough of 400.74% in Q4 2021.
  • Its 5-year average for FCF Margin is 106.07%, with a median of 57.77% in 2023.
  • In the last 5 years, Legend Biotech's FCF Margin plummeted by -2383400bps in 2023 and then surged by 3945200bps in 2024.
  • Legend Biotech's FCF Margin (Quarter) stood at 400.74% in 2021, then skyrocketed by 74bps to 104.28% in 2022, then surged by 100bps to 0.17% in 2023, then surged by 54bps to 0.08% in 2024, then surged by 16414bps to 12.41% in 2025.
  • Its FCF Margin stands at 12.41% for Q3 2025, versus 1.5% for Q2 2025 and 52.17% for Q1 2025.